Behrenbruch Christian

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
North Melbourne, Australia
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Oliver Newman, on behalf of Dr. Christian Behrenbruch, MD & Group CEO
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Behrenbruch Christian

Form 4 holding MD & Group CEO, Director

Telix Pharmaceuticals Ltd

Security class
American Depositary Receipts
Shares / value
400,000
Estimated value
Report date
18 Mar 2026
Price
Ownership
Direct

Insider Reports Filed by Behrenbruch Christian

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .